Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IP Investimenti e Partecipazioni is an Italian investment holding company and private equity firm controlled by the Denegri family. Based in Turin, the company is primarily recognized as the controlling shareholder of DiaSorin S.p.A., a global leader in the in vitro diagnostics (IVD) market. The firm specializes in long-term industrial investments, particularly within the healthcare, medical technology, and life sciences sectors. Beyond its stake in DiaSorin, IP Investimenti e Partecipazioni manages a diverse portfolio of medical technology companies through vehicles like IP Medical Capital, focusing on areas such as cardiovascular health, orthopedics, and surgical devices. The company plays a strategic role in the governance and growth of its portfolio entities, leveraging its deep expertise in the global healthcare industry. It operates as a private entity, providing capital and strategic direction to businesses that drive innovation in clinical diagnostics and medical treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IP Investimenti e Partecipazioni.